World's 1st transplant of iPS heart muscle tissue

World's 1st transplant of iPS heart muscle tissue

Osaka University professor Yoshiki Sawa (R) attends a press conference in Suita, Osaka Prefecture, on Jan. 27, 2020, to announce the world's first transplant of heart muscle tissue using artificially derived stem cells known as iPS. (Kyodo) ==Kyodo

  • Product Code
  • ILEA000172813
  • Registered date
  • 2020/1/27 18:57:31
  • Credit
  • Kyodo / Kyodo News Images
  • Media source
  • 2020 Kyodo News
  • Media size
  • 3968 × 2783 pixel
  • Resolution
  • 240 dpi
  • Deployment size
  • 611.22(KB)*
  • Special instruction

*File size when opened in Photoshop, etc.

Similar Images & Videos
    World's 1st transplant of iPS heart muscle tissue

    World's 1st transplant of iPS heart muscle tissue

    Osaka University professor Yoshiki Sawa (L) attends a press conference in Suita, Osaka Prefecture, on Jan. 27, 2020, to announce the world's first transplant of heart muscle tissue using artificially derived stem cells known as iPS. (Kyodo) ==Kyodo
      World's 1st transplant of iPS heart muscle tissue

      World's 1st transplant of iPS heart muscle tissue

      Osaka University professor Yoshiki Sawa attends a press conference in Suita, Osaka Prefecture, on Jan. 27, 2020, to announce the world's first transplant of heart muscle tissue using artificially derived stem cells known as iPS. (Kyodo) ==Kyodo
        World's 1st transplant of iPS heart muscle tissue

        World's 1st transplant of iPS heart muscle tissue

        Osaka University professor Yoshiki Sawa attends a press conference in Suita, Osaka Prefecture, on Jan. 27, 2020, to announce the world's first transplant of heart muscle tissue using artificially derived stem cells known as iPS. (Kyodo) ==Kyodo
          World's 1st transplant of iPS heart muscle tissue

          World's 1st transplant of iPS heart muscle tissue

          Osaka University professor Yoshiki Sawa (C) attends a press conference in Suita, Osaka Prefecture, on Jan. 27, 2020, to announce the world's first transplant of heart muscle tissue using artificially derived stem cells known as iPS. (Kyodo) ==Kyodo
            World's 1st transplant of iPS heart muscle tissue

            World's 1st transplant of iPS heart muscle tissue

            Osaka University professor Yoshiki Sawa (C) attends a press conference in Suita, Osaka Prefecture, on Jan. 27, 2020, to announce the world's first transplant of heart muscle tissue using artificially derived stem cells known as iPS. (Kyodo) ==Kyodo
              Retina transplants via donor iPS cells

              Retina transplants via donor iPS cells

              Masayo Takahashi, a researcher at the Japanese government-backed Riken institute, speaks at an academic conference in Tokyo on April 18, 2019. Five patients suffering a severe eye disease were doing well a year after they received in 2017 the world's first transplant surgeries using induced pluripotent stem cells from donors, she said. (Kyodo) ==Kyodo
                Retina transplants via donor iPS cells

                Retina transplants via donor iPS cells

                Photo taken Nov. 10, 2017, shows Masayo Takahashi, a researcher at the Japanese government-backed Riken institute. She said in Tokyo on April 18, 2019 that five patients suffering a severe eye disease were doing well a year after they received in 2017 the world's first transplant surgeries using induced pluripotent stem cells from donors. (Kyodo) ==Kyodo
                  World's 1st test using iPS cells to treat corneal disease

                  World's 1st test using iPS cells to treat corneal disease

                  Osaka University professor Koji Nishida speaks at a press conference in Tokyo on March 5, 2019, about the world's first clinical test to treat patients with a corneal disease by using artificially derived stem cells. (Kyodo) ==Kyodo
                    World's 1st test using iPS cells to treat corneal disease

                    World's 1st test using iPS cells to treat corneal disease

                    Osaka University professor Koji Nishida (2nd from R) speaks at a press conference in Tokyo on March 5, 2019, about the world's first clinical test to treat patients with a corneal disease by using artificially derived stem cells. (Kyodo) ==Kyodo
                      Use of iPS cells to treat spinal cord injuries

                      Use of iPS cells to treat spinal cord injuries

                      Keio University professor Hideyuki Okano speaks in Tokyo on Feb. 18, 2019, about the use of induced pluripotent stem cells to treat patients suffering from the loss of motor function due to spinal cord injuries. (Kyodo) ==Kyodo